Speech-Language Pathologists in Alameda, CA Accepting Medicare

19 Speech-Language Pathologists found. Showing 1 - 19

Susan Diamond, M.A.,CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2916 San Jose Ave, Alameda, CA 94501 Phone: 510-814-0555

Ms. Amy Rachel Roman, M.S., CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1420 9th St, Alameda, CA 94501 Phone: 415-518-0592

Ms. Susan E Walburn, M.A.-CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1225 Park Ave, Apt. C, Alameda, CA 94501 Phone: 415-250-3019

Mrs. Mary Macpherson, M.A. (SPEECH LANGUAG Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2308 Central Ave., Alameda, CA 94501 Phone: 510-499-5437

Hilary Elizabeth Cote, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1032 San Antonio Ave, Alameda, CA 94501 Phone: 510-521-1336

Mrs. Janet Hachiya, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2933 Sea View Pkwy, Alameda, CA 94502 Phone: 510-543-7040

Cecilia Lindsay, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1230 Pearl St, Alameda, CA 94501 Phone: 415-559-9349

Nicole Trawick, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2159 Clinton Ave, Alameda, CA 94501 Phone: 972-743-4858

Heather Quinones, MA MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1209 Park St Apt 2, Alameda, CA 94501 Phone: 818-429-9857

Amanda Michele Gean, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1164 Broadway, Alameda, CA 94501 Phone: 415-238-8418

Stephanie Lee, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2519 Lincoln Ave, Alameda, CA 94501 Phone: 510-210-3930

Ms. Laurie F Bochner, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 22 Coleport Lndg, Alameda, CA 94502 Phone: 510-521-7629

Grace Shefcik Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2465 Shoreline Dr, Alameda, CA 94501 Phone: 925-794-0746

Michelle Silber, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2465 Shoreline Dr, Alameda, CA 94501 Phone: 832-674-0982

Mrs. Rachel Hoover, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1777 Shoreline Dr, Alameda, CA 94501 Phone: 707-200-1207

Adrianna Kaspar, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2001 Santa Clara Ave, Alameda, CA 94501 Phone: 510-883-3922

Alameda Speech Therapy, Inc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2001 Santa Clara Ave, Alameda, CA 94501 Phone: 510-883-3922

The Superspeech & Language Connection Lp Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2150 Mariner Square Dr, Suite 101, Alameda, CA 94501 Phone: 510-306-9066

Courtney Noelle Bridge Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1219 Pease Ct, Alameda, CA 94501 Phone: 772-353-2150

News Archive

Interfering RNA nanoparticles could be a potential COVID-19 therapy

Study shows lipid nanoparticle-based siRNA is potent in suppressing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the causative agent of coronavirus disease 2019 (COVID-19) – in cells as well as in mice models.

Researchers discover new disease mechanism in chronic tobacco smokers

Research published in the journal Clinical Science suggests that an immune signaling protein called interleukin-26 is increased among chronic smokers with lung disease and this involvement reveals disease mechanisms of interest for developing more effective therapy for these hard-to-treat patients.

Positive results from recently completed phase II clinical study of ToleroMune therapy announced

Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced positive results from a recently completed phase II clinical study of its ToleroMune(R) cat allergy therapy, which successfully identified the optimal dosing regimens to progress into late-stage development.

Counties with more socially vulnerable populations face a greater risk of water and air pollution

An analysis led by North Carolina State University researchers found counties with more socially vulnerable populations had a higher density of natural gas pipelines overall.

New report reveals high levels of caffeine in energy drinks could lead to cardiac complications

The high levels of caffeine in energy drinks may lead to cardiac complications, suggests a case report in the July/August Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine. The journal is published by Wolters Kluwer.

Read more Medical News

› Verified 9 days ago